Dolan Chantal M, Fraher Kyle E, Bleecker Eugene R, Borish Larry, Chipps Bradley, Hayden Mary Lou, Weiss Scott, Zheng Beiyao, Johnson Charles, Wenzel Sally
Genentech Inc, South San Francisco, California 94080, USA.
Ann Allergy Asthma Immunol. 2004 Jan;92(1):32-9. doi: 10.1016/S1081-1206(10)61707-3.
Patients with severe and difficult-to-treat asthma represent a small percentage of asthma patients, yet they account for much of the morbidity, mortality, and cost of disease. The goal of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study is to better understand the natural history of asthma in these patients.
To describe the methods and baseline characteristics of the TENOR study cohort.
The TENOR study is a 3-year, multicenter, observational study of patients with severe or difficult-to-treat asthma. From January through October 2001, more than 400 US pulmonologists and allergists enrolled patients. Patients 6 years or older who were considered to have severe or difficult-to-treat asthma by their physicians were eligible. Patients have been receiving care for 1 year or more, have a smoking history of 30 pack-years or less, and have current high medication or health care utilization in the past year. Data are collected semiannually.
A total of 4,756 patients enrolled and completed a baseline visit. Overall, 73% of the TENOR study patients are adults, 10% are adolescents, and 16% are children. According to physician evaluation, 48% of patients have severe asthma, 48% have moderate asthma, 3% have mild asthma, and 96% have difficult-to-treat asthma. Severe asthmatic patients have the highest health care utilization in the past 3 months (P < .001).
The TENOR study is the largest cohort of patients with severe or difficult-to-treat asthma. Although patients are equally divided into moderate or severe asthma categories, most are considered difficult-to-treat. The TENOR study highlights the lack of control in moderate-to-severe asthma and provides a unique opportunity to examine factors related to health outcomes in this understudied population.
重度且难治性哮喘患者在哮喘患者中占比小,但却导致了大量的发病、死亡及疾病花费。哮喘的流行病学和自然史:转归与治疗方案(TENOR)研究的目的是更好地了解这些患者哮喘的自然史。
描述TENOR研究队列的方法和基线特征。
TENOR研究是一项针对重度或难治性哮喘患者的为期3年的多中心观察性研究。2001年1月至10月,400多名美国肺科医生和过敏症专科医生招募患者。年龄在6岁及以上、被医生认为患有重度或难治性哮喘的患者符合条件。患者已接受治疗1年或更长时间,吸烟史为30包年或更少,且在过去一年中有当前高药物治疗或高医疗保健利用率。数据每半年收集一次。
共有4756名患者入组并完成了基线访视。总体而言,TENOR研究患者中73%为成年人,10%为青少年,16%为儿童。根据医生评估,48%的患者患有重度哮喘,48%患有中度哮喘,3%患有轻度哮喘,96%患有难治性哮喘。重度哮喘患者在过去3个月中的医疗保健利用率最高(P <.001)。
TENOR研究是最大的重度或难治性哮喘患者队列。尽管患者在中度或重度哮喘类别中平分,但大多数被认为是难治性的。TENOR研究突出了中重度哮喘缺乏控制的情况,并为研究这一研究不足人群中与健康转归相关的因素提供了独特机会。